0001209191-17-036620.txt : 20170531 0001209191-17-036620.hdr.sgml : 20170531 20170531210150 ACCESSION NUMBER: 0001209191-17-036620 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170526 FILED AS OF DATE: 20170531 DATE AS OF CHANGE: 20170531 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-742-3400 MAIL ADDRESS: STREET 1: 7555 GATEWAY BLVD. CITY: NEWARK STATE: CA ZIP: 94560 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SILVERNAIL LAUREN P CENTRAL INDEX KEY: 0001225755 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 17883016 MAIL ADDRESS: STREET 1: 15279 ALTON PARKWAY STREET 2: SUITE #100 CITY: IRVINE STATE: CA ZIP: 92618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-26 0 0001479290 Revance Therapeutics, Inc. RVNC 0001225755 SILVERNAIL LAUREN P C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560 0 1 0 0 CFO, CBO & Secretary Common Stock 2017-05-26 4 M 0 23000 8.70 A 59566 D Stock Option (Right to Buy) 8.70 2017-05-26 4 M 0 23000 0.00 D 2023-05-23 Common Stock 23000 73373 D The Option became fully vested as of March 18, 2017. /s/ Gordon Ho, Attorney-in-fact 2017-05-31